Tingling and Numbness

7/25/2019 Tingling and Numbness

1/67

Tingling andNumbness

Group 12:

CORPUS, KRIZZELLE

ODIGILI, PHILIP

REPATO, ALDRIN A.

REYES, SARAH M.

ROSARIO, WINSTONE

RUDANI, KAUSHAL

SANTILLAN, KENNETH S.

7!1" 1


2/67

OUTLINEI. Tingling and NumbnessS#$op%&%

T'r(&$o)o*#Ep&+'(&o)o*#A$-o(# $+ P-/#%

D'r(-o('%Clinical Practice Guidelines:R&%0 -or%H&%-or# T0&$*

7!1" 2


3/67

OUTLINED&*$o%&%C)&$&) E3(&$-&o$

L4. T'%-A)*or&-(

R'+ )*%

II. Hypotetical CaseIII. E!idence "ased #edicine

7!1" !


4/67

$%NOP$I$

umbness$+ tinglingr' 4$or() %'$%-&o$%-- $ our $#/'r' &$ #our 4o+#, 4u- r'o5-'$ 5')- &$ #our 6$*'r%, $+%, 5''-, r(%, or )'*%.

Tingling

8pins and needles

9$ 4$or() po%&-&' %#(p-o( o5 +&%or+'r'+%'$%-&o$.

umbness8 o$%&+'r'+ % $'*-&' %#(p-o(+u' -o )o%% o5 %'$%or# 5u$-&o$ $+ +&(&$&%'+ or4%'$- 5'')&$*

7!1"Harrison&s Principles o' Internal#edicine( )*t Edition ;


5/67

SYNOPSIST/o C-'*or&'% o5 4$or() S#(p-o(%:

Positive $+ egative Symptoms

Pro-o-#p&) Po%&-&' S#(p-o(:

Tingling ( pins and needles)

I-, pr&0&$*, )&*-$&$* )&0' %oo-&$* 5'')&$*%


6/67

SYNOPSISPositive Phenomena

-r&$% o5 &(pu)%'% *'$'r-'+ - %&-'% o5 )o/'r'+

-r'%o)+ or '&*-'$'+ '3&-4&)&-# )o$* p'r&p'r) or '$-r) %'$%or# p-/#.

egative Phenomena

)o%% o5 %'$%or# 5u$-&o$.+&(&$&%'+ or 4%'$- 5'')&$*.

umbness

7!1"Harrison&s Principles o' Internal#edicine( )*t Edition "


7/67

TE+#INOLOG%Paresthesias8 r'5'r% -o -&$*)&$* or p&$%9$+9$''+)'%%'$%-&o$% 4u- (# &$)u+' /&+' r&'-# o5 o-'r4$or() %'$%-&o$%, '3'p- p&$? &- &% %o('-&('% &(p)&'%

-- -' 4$or() %'$%-&o$% r' p'r'&'+ %po$-$'ou%)#.

Dysthesias

8 (or' *'$'r) -'r(

9D'$o-'% )) -#p' o5 4$or() %'$%-&o$%, &$)u+&$* p&$5u)o$'%, r'*r+)'%% o5 /'-'r %-&(u)u% &% '&+'$-.

Hypesthesia or hypoesthesia8 r'5'r% -o r'+u-&o$ o5u-$'ou% %'$%-&o$ -o %p'&6 -#p' o5 -'%-&$* %u %pr'%%ur', )&*- -ou, $+ /r( or o)+ %-&(u)&

7!1"Harrison&s Principles o' Internal#edicine( )*t Edition 7


8/67

TE+#INOLOG%Anesthesia8 o(p)'-' 4%'$' o5 %0&$ %'$%-&o$ -o -'%(' %-&(u)& p)u% p&$pr&0

Hypalgesia or analgesia8 -o r'+u' or 4%'$- p&$

p'r'p-&o$


9/67

EPIDEMIOLOGYA% *' pro*r'%%'%, o$' ou- o5 -r'' p'op)'

%u'r 5ro( $'urop-# or $'r' +(*'.

I- &% )%o '%-&(-'+ -- rou$+ 1B -o 1>(&))&o$ &)&p&$o% ' $'urop-#.

N'urop-# '-% p'op)' /o ' $u$4)$'+ +&'- $+ u$')-# )&5'%-#)', /&

&$)u+'% %(o0&$*, )oo) +r&$0&$*, or -o%'/o + &$ur&'% or ' +&4'-'%.


10/67

ANATOMY


11/67

Spinothalamic Pathway


12/67

DERMATOMES

7!1" 12


13/67

,E+#-TO#E$ $ r' o5 %0&$ -- &% %'r'+ 4# %&$*)' %p&$)

$'r'.

+'r&'+ 5ro( -' '))% o5 %o(&-'.

(&)&r&-# /&- -' +'r(-o('% &% )&$&))# u%'5u)

&$ )o)&&$* -' )'%&o$ -o $'r' roo- or %p&$)or+ pr-&u)r)# &$ r+&u)op-#.

T' ) spine segments o$ ' %&+' *&' r&%' -o!1 %p&$) $'r'%, /& r' o(po%'+ o' /cer!ical( )0 toracic( 1 lumbar( 1 sacral( and )coccygeal spinal ner!e. ,ermatomes '3&%- 5or

' o5 -'%' %p&$) $'r'%, '3'p- -' 6r%- 'r&)%p&$) $'r'. S'$%or# &$5or(-&o$ 5ro( %p'&6+'r(-o(' &% -r$%(&--'+ 4# -' %'$%or# $'r'64'r% -o -' %p&$) $'r' o5 %p'&6 %'*('$- o5-' %p&$) or+.

tora2 and abdomen, -' +'r(-o('% r' ''$)#

%p'+ %'*('$-% %-0'+ up o$ -op o5 ' o-'r,$+ ' &% %upp)&'+ 4# +&'r'$- %p&$) $'r'.

arms and legs3 +&'r 5ro( -' p--'r$ o5 -' -ru$0+'r(-o('%, 4'u%' -'# ru$ )o$*&-u+&$))# )o$*-' )&(4%. T' *'$'r) p--'r$ &% %&(&)r &$ ))p'op)', 4u- %&*$&6$- r&-&o$% '3&%- &$ +'r(-o('

(p% 5ro( p'r%o$ -o p'r%o$

REFERENCE:http://emedicine.medscape.com/article/188!88"o#er#ie$


14/67

LOC-LI4-TION

7!1"Harrison&s Principles o' Internal#edicine( )*t Edition 1;

NE+5E -N, +OOTNer!e trun6 lesion7 u%' %'$%or#4$or()&-&'%

+oot radicular lesion 8 +''p &$* p&$ )o$*-' our%' o5 -' r')-'+ $'r' -ru$0Upper Cer!ical cord lesion 8 '-% 4o- $+%$+ 5''-Upper motor lesion7 %p&$-'r &$o)'('$-Central8"rainstem Lesion7 S'$%or#+&%-ur4$', '-% )) '3-r'(&-&'%, u%'%%#$*o(#')&$pinal cord Lesion7 S'$%or# +&%%o&-&o$,

$u(4$'%% or pr'%-'%&% &$ 4o- 5''-.


15/67

LOC-LI4-TION"+-IN$TE# $mall lesion in te brainstem7 +(*' 4o- &p%&)-'r)

+'%'$+&$* -&*'(&$0 -r- $+ %'$+&$* %p&$o-)(& 64'r%

Lesion in te tegmentum o' Pons and #idbrain9 u%'%p$%'$%or# )o%% o$-r)-'r))#

Lesion in te Talamus7 )$u)r &$5r-&o$, /& '-% PL$u)'u%, u%'% T)(& p&$ r'5'rr'+ -o %, D''$$'9Rpu%%#%#$+ro('.

CO+TE9

Parietal lobe lesion7 o$-r)-'r) '(&$'*)'-, '(&&$--'$-&o$, -'$+'$# $o- -o u%' -' '-'+ $+ or r(

-nterior Parietal in'arction7 p%'u+o-)(& %#$+ro(' /&-o$-r)-'r))o%% o5 pr&(r# %'$%-&o$5ro( '+ -o -o',

7!1"Harrison&s Principles o' Internal#edicine( )*t Edition 1>


16/67

+I$ ;-CTO+$ Extra weight.Being overweight or obese may

increase the pressure on your lateral femoral

cutaneous nerve

Pregnancy.A growing belly puts a!!e! pressure

on your groin" through which the lateral femoralcutaneous nerve passes

Diabetes.#iabetes$relate! nerve in%ury can lea!

to meralgia paresthetica

Age.People between the ages of &' an! (' are

at a higher ris)

Lifestyle habits A se!entary lifestyle an! poor

nutrition*+itamin B comple,- are ma%or ris) factors


17/67

HI$TO+% T-ING W- pr- or pr-% o5 #our 4o+# ' $u(4$'%%

or -&$*)&$*F T' -ru$0F Your )'*% or 5''-F Yourr(%, $+%, or 6$*'r%F

W& %&+' o5 #our 4o+# &% &$o)'+F W& r' o5 -- 4o+# pr-F or '3(p)', &%

#our &$$'r -&*, )5, or 5oo- '-'+F Your p)(,6$*'r%, -u(4, /r&%-, or 5or'r(F

Do'% -' $u(4$'%% or -&$*)&$* '- #our 5'FArou$+ #our '#'%F Your ''0%F Arou$+ #our(ou-F I% o$' or 4o- %&+'% o5 #our 5'&$o)'+F

7!1" Pennstateersey.adam 17


18/67

HI$TO+% T-ING Do'% -' pr- o5 #our 4o+# /&- $u(4$'%% or

-&$*)&$* $*' o)or%F Do'% &- 5'') o)+ or/r(F

Do #ou ' o-'r 4$or() %'$%-&o$%F

Do #ou &*$or' ''r#-&$* o$ -' '-'+%&+'F

Ho/ )o$* ' #ou + -' $u(4$'%% or-&$*)&$*F

W'$ +&+ &- %-r-F

Do'% $#-&$* (0' &- /or%', %u %

'3'r&%' or %-$+&$* 5or )o$* p'r&o+% o5 -&('F7!1" Pennstateersey.adam 1@


19/67

+E5IE< O; $%$TE#General

W'&*- )o%% or *&$

-&*u' ''r or &))%

W'0$'%%

Trou4)' %)''p&$*

Neurologic

D&&$'%%

&$-&$*

S'&ur'%

W'0$'%%

Nu(4$'%% T&$*)&$*

Tr'(or

7!1"

"-TE$=$ Guide to Pysical

E2amination and History Ta6ing( ))tedition 1


20/67

,I;;E+ENTI-L ,I-GNO$I$Common:

DM 1 $+ 2A)oo)&%(Upp'r $+ Lo/'r E3-r'(&-# N'urop-&'%Au-' S-r'%% D&%or+'r

H#p'r'$-&)-&o$

S-ro0' S#$+ro('R'$) &)ur'

H'rp'% o%-'r


21/67

,i>erential ,iagnosisOccasional

Dru*%Nu-r&-&o$) D'6&'$#

R'%-)'%% L'*% S#$+ro('Gu&))&$9rrJ %#$+ro('Cr$&) N'r' N'urop-&'%H#po-#ro&+&%(

L'pro%#Sro&+o%&%L#(' D&%'%'M'-4o)&

7!1"

,I-GNO$I$( - $ymptom7based

-pproac in Internal #edicine.( C$#adgaon6ar 21


22/67

,i>erential ,iagnosis+are

%u)&-&% S#$+ro('Mu)-&p)' M#')o(

Ho+*0&$% +&%'%'Pr$'op)%-& %#$+ro('M)&*$$#D&p-'r&Porp#r&To3&$%D''r&$'9Rou%%# %#$+ro('CIDPH'r'+&-r#

7!1"

,I-GNO$I$( - $ymptom7based

-pproac in Internal #edicine.( C$#adgaon6ar 22


23/67

Clinical E2amination o'

$ensationPrimary $ensation

Pain9 P&$%Temperature9 /r( or o)+Touc9 /&%p?oint Position Testing7 propr&o'p-&o$5ibration7 -u$&$* 5or0

@uantitati!e $ensory Testing%'r&) ')u-&o$ o5 u-$'ou% %'$%-&o$% &$

)&$&) -r&)%

7!1"Hrr&%o$% Pr&$&p)'% o5 I$-'r$) M'+&&$',1- E+&-&o$ 2!


24/67

7!1" --p:///.(r9%#%-'(%.+''$*)&%pro+u- 2;
http://www.mrc-systems.de/englisch/products/pinprick.htmlhttp://www.mrc-systems.de/englisch/products/pinprick.htmlhttp://www.mrc-systems.de/englisch/products/pinprick.html


25/67

7!1" --p:///.%)&+'%r'.$'-ooZ;2$+9#'r99 9 9 9

2>
http://www.slideshare.net/ooZ94/2nd-year-ospe-sensory-motor-special-sensehttp://www.slideshare.net/ooZ94/2nd-year-ospe-sensory-motor-special-sensehttp://www.slideshare.net/ooZ94/2nd-year-ospe-sensory-motor-special-sensehttp://www.slideshare.net/ooZ94/2nd-year-ospe-sensory-motor-special-sense


26/67

7!1" 2"///.#ou-u4'.o(
http://www.youtube.com/http://www.youtube.com/


27/67

7!1" --p:///.%)&+'%r'.$'-A)4'r-)'$'9 9

27
http://www.slideshare.net/AlbertBalace/neurological-assessment-23915266http://www.slideshare.net/AlbertBalace/neurological-assessment-23915266http://www.slideshare.net/AlbertBalace/neurological-assessment-23915266http://www.slideshare.net/AlbertBalace/neurological-assessment-23915266


28/67

7!1" --p:///.o%'%0&))%.o('9)'r$&$*%u4'9 9 9

2@
http://www.osceskills.com/e-learning/subjects/lower-limb-neurological-examination/http://www.osceskills.com/e-learning/subjects/lower-limb-neurological-examination/http://www.osceskills.com/e-learning/subjects/lower-limb-neurological-examination/http://www.osceskills.com/e-learning/subjects/lower-limb-neurological-examination/


29/67

7!1" --p:///.o%'%0&))%.o('9)'r$&$*%u4'9 9 9

2
http://www.osceskills.com/e-learning/subjects/lower-limb-neurological-examination/http://www.osceskills.com/e-learning/subjects/lower-limb-neurological-examination/http://www.osceskills.com/e-learning/subjects/lower-limb-neurological-examination/http://www.osceskills.com/e-learning/subjects/lower-limb-neurological-examination/


30/67

7!1" --p:///.$'uro'3(.o($'uro'3(o$

!B
http://www.neuroexam.com/neuroexam/content.php?p=40http://www.neuroexam.com/neuroexam/content.php?p=40http://www.neuroexam.com/neuroexam/content.php?p=40http://www.neuroexam.com/neuroexam/content.php?p=40


31/67

7!1" --p:///.$'uro'3(.o($'uro'3(o$

!1


32/67

7!1" --p:///.$'uro'3(.o($'uro'3(o$

!2


33/67

7!1" --p:///.$'uro'3(.o($'uro'3(o$

!!


34/67

7!1" --p:///.$'uro'3(.o($'uro'3(o$

!;

CLINIC-L E9-#


35/67

CLINIC-L E9-#

Cro$& &$((-or# +'(#')&$-&$*

po)#r+&u)o$'urop-#


36/67

E9-#IN-TION O;

$EN$-TIONCortical $ensationTAo7point ,iscrimination9 %p'&) )&p'rTouc LocaliBation9 )&*- pr'%%ur'? /&%p o5

o--o$ /oo)&)-'r) S&(u)-$'ou% S-&(u)-&o$%Grapestesia9 )'--'r%, $u(4'r% p)( o5

$+$tereognosis9 0'#%, pp'r )&p%, o&$%.

7!1"Hrr&%o$% Pr&$&p)'% o5 I$-'r$) M'+&&$',1- E+&-&o$ !"


37/67

L-"O+-TO+% TE$T$General Lab testsC"C7iron deciency anemia( macrocytic

anemia and Leu6ocytosis

E$+7 systemic and inDammatory processes

"lood( Glucose( Urea( Creatinine(Electrolytes

C9+7rule out lung cancer and sarcoidosis

97ray

7!1" Hrr&%o$% Pr&$&p)'% o5 I$-'r$) M'+&&$',1- E+&-&o$ !7


38/67

L-"O+-TO+% TE$T$Sp'&6 L4 -'%-%T$H7 #po-#ro&+&%(.Ner!e Conduction $tudy NC$F7-#p' o5 PN,

3o$) 5ro( +'(#')&$-&$* $'urop-&'%.CT8#+I7 %-ro0'? 'r&), -or&, %p&$)

o(pr'%%&' %#$+ro('%? -or& ou-)'-%#$+ro('? (u)-&p)' %)'ro%&%? 4r&)

p)'3u%'&+'$' o5 &$6)-r-&$* P$o%- )'%&o$.

7!1" Hrr&%o$% Pr&$&p)'% o5 I$-'r$) M'+&&$',1- E+&-&o$ !@


39/67

L-"O+-TO+% TE$T$$pecic Lab tests

Ner!e "iopsy7 &$((-or#, &$5'-&ou%, $+('-4o)& PN%.

Lyme Titer7 L#(' +&%'%' ($&5'%--&o$%.C$; -nalysis7 &$((-or#, &$5'-&ou%, r&'-#

o5 &((u$'('+&-'+ PN%

$erum Protein Electroporesis and

Immuno2ation7 (u)-&p)' (#')o( oro%-'o%)'ro-& (#')o(

To2ic $creen

Genetic Test

7!1" Harrison&s Principles o' Internal#edicine( )*t Edition !


40/67

-LGO+ITH# O; TINGLING-N, NU#"NE$$ +EL-TE,

NEU+OP-THIE$


41/67

7!1" Hrr&%o$% Pr&$&p)'% o5 I$-'r$) M'+&&$',1- E+&-&o$ ;1


42/67

7!1" Hrr&%o$% Pr&$&p)'% o5 I$-'r$) M'+&&$',1- E+&-&o$ ;2


43/67

RED LAGS

Su++'$ o$%'- o5 $u(4$'%% Su++'$ or rp&+ o$%'- o5 /'0$'%% D#%p$' S&*$% o5 u+ 'u&$ or o$u% ('+u))r&%

%#$+ro(' N'uro)o*& +'6&-% 4')o/ %p&$) %'*('$-

7!1" #$, #anualttp:88AAA.gponline.com ;!


44/67

RED LAGS

Lo%% o5 %'$%-&o$ o$4o- -' 5' $+ 4o+#


45/67

+E, ;L-G$ O; NU#"NE$$8TINGLING

Su++'$ o$%'- o5 $u(4$'%% Su++'$ or rp&+ o$%'- o5

/'0$'%% D#%p$' S&*$% o5 u+ 'u&$ or o$u%

('+u))r&% %#$+ro(' N'uro)o*& +'6&-% 4')o/ %p&$)

%'*('$- Lo%% o5 %'$%-&o$ o$ 4o- -'

5' $+ 4o+#


46/67

H%POTHETIC-LC-$E


47/67

H#po-'-&) C%'A >"9#'r9o)+ ($, pr'&ou%)# /')), pr'%'$-% -o &%pr&(r# r' p#%&&$ /&- ;9(o$- &%-or# o5 4ur$9&$* p&$ &$ -' %o)'% o5 &% 5''-. T' p&$ &% +'%r&4'+

% 4'&$* /or%' - $&*-5r'u'$-)# % pr''$-'+ &(5ro( 5))&$* %)''p, $+ % r''$-)# 4''$ /0'$&$*&( 5ro( %)''p. H' 5ou$+ -- '-(&$op'$ -4)'-%+&+ $o- r')&'' -' p&$. H' + $o-&'+ %o(' +#-&('$u(4$'%% $+ -&$*)&$* %'$%-&o$% %-r-&$* - 4ou- -'

%(' -&(', $+ &$ -' %(' +&%-r&4u-&o$ % -' p&$. H'+&+ $o- ' /'0$'%%, )o/ 40 p&$, 4o/') or4)++'r +&%-ur4$'%, 4u- % '3p'r&'$'+ 'r'-&)'+#%5u$-&o$ &$ -' )%- 1 -o 2 (o$-%.


48/67

CHIE COMPLAINur$&$* P&$ &$ -' %o)'% o5 &% 5''-D#-&(' -&$*)&$* $+ $u(4$'%% %'$%-&o$%

Er'-&)' D#%5u$-&o$ 5or -' )%- 192 (o$-%

7!1" Hrr&%o$% Pr&$&p)'% o5 I$-'r$) M'+&&$',1- E+&-&o$ ;@


49/67

#E,IC-L HI$TO+%T' p-&'$-% ('+&) &%-or# /% %&*$&6$-5or $ pp'$+'-o(# 2B #'r% *o

H#p'r-'$%&o$ 5or 1 #'r, $+ $ 'p&%o+' o5u-' *ou- &$ -' )'5- 6r%- -o' > #'r% *o

S'%o$) ))'r*&'% -o *r%% $+ r*/''+. H'-0'% ('-opro)o) 2> (* o$' +&)#.


50/67

+E5IE< O; $%$TE#$5'')% /')) $+ &% /'&*- &% %-4)'.% *oo+ pp'-&-'.

'3p'r&'$'% )&*-9'+'+$'%% o$ %-$+&$* u&0)#,

4u- +o'% $o- ' %#$op) 'p&%o+'%.+o'% $o- ' '+'%, $or +o'% ' '

$*'% &$ &%&o$ or 4u)4r 5u$-&o$%.

H' +'$&'% %or-$'%% o5 4r'-, '%- p&$, or

p)p&--&o$%?5ur-'r(or', -'r' &% $o &%-or# o5 $u%',

o(&-&$*, or 4+o(&$) p&$, 4u- ' % $o-'+ro$& o$%-&p-&o$


51/67

;-#IL% HI$TO+%T' p-&'$-% 5-'r +&'+ - *' "> o5 (#or +&) &$5r-&o$.

H&% (o-'r + -#p' 2 +&4'-'% ('))&-u%, $++&'+ - *' 7B o5 %-ro0'.

H' % 2 4ro-'r%, *'+ "B $+ >;-' 6r%-% +&4'-'%, #p'r-'$%&o$, $+ o4'%&-#, $+-' %'o$+ % &%-or# o5 (#or+&)&$5r-&o$.

T' p-&'$- % ! &)+r'$, 2 o5 /o( r'o'r/'&*-.


52/67

$OCI-L HI$TO+%T' p-&'$- /% 4or$ $+ r&%'+ &$ O%/, O$-r&o,C$+, $+ /or0% - G'$'r) Mo-or% % )&$'&$%p'-or.

'$o#% /-&$* %por-% o$ -')'&%&o$.H' )oo0% 5-'r -' #r+, 4u- +o'% $o- p)# $# %por-% or

4')o$* -o *#(.

+r&$0% 2 -o ! 4''r% +&)# $+ +ou4)' -&% (ou$- o$/''0'$+ +#%.

%(o0'% 2 p0% o5 &*r'--'% +&)#, $+ % +o$' %o 5or!B #'r%.

% $o- u%'+ r'r'-&o$) +ru*% %u % (r&u$,o&$', or 'ro&$


53/67

PH%$IC-L E9-#IN-TIONpp'r% -o 4' $ )'r-, oop'r-&', $+ o4'%' ($/o pp'r% o)+'r -$ &% %--'+ *'

(&)+ +&%-r'%% +u' -o +&%o(5or- &$ &% 5''-

W'&*-: 2!B )4%,

P 1>B> (( H* HR:1B; 4p( $+ r'*u)r

RR&% 1" 4r'-% p'r (&$u-'

o+# T'(p: !7QC.

T' r$&) $'r'% r' $or().H&% $'0 &% %upp)'.

T'r' &% %o5- )'5- ro-&+ 4ru&- 'r+ +ur&$* %#%-o)'.

T'r' &% $o u*u)r '$ou% +&%-'$%&o$.


54/67

PH%$IC-L

E9-#IN-TIONT' -#ro&+ &% $or() &$ %&'.T' '%- &% $or() $+ 4r'- %ou$+% $or().

T' %'o$+ 'r- %ou$+ &% '$-u-'+, $+ -'r'

r' $o (ur(ur% or -r&))%.T' 4+o('$ &% +&%-'$+'+, 4u- $o$-'$+'r -o

p)p-&o$ /&- $or() 4o/') %ou$+% $+ $o'p-o%p)'$o('*)#.

T' *'$&-)& r' $or(), % &% r'-) -o$'.T' p-&'$- % +r# %0&$ o$ -' )o/'r '3-r'(&-&'%.

T' %0&$ &% (o--)'+ $+ oo) /'$ +'p'$+'$-

P & ) ) ) + + -


55/67

P'r&p'r) pu)%'% r' $or(), $+ ' +o'% $o-' '#(o%'%, p'-'&', or r%'%.

H' +o'% $o- ' p'+) '+'(.

T' p-&'$- pp'r% -o ' $or() %-r'$*-.

H&% $0)' r''3'% r' 4%'$-.

S'$%or# )o%% &$ -' 5''- &% %%u('+ -o 4'

pr'%'$- o$ p)p-&o$, 4u- $o o4'-&' -'%-%r' p'r5or('+.

H&% *&- &% $or().


56/67

NEU+OLOG% CON$ULT-TION

-' p-&'$- + -' %(' %#(p-o(% %pr'&ou%)# +'%r&4'+

T' p-&'$- % $o-'+ '3'%%&' -&r%- $+ur&$-&o$ 5or -' )%- @ (o$-%. H&% /'&*- %

4''$ %-4)'. H' &% 4'o(&$* +'pr'%%'+ 4ou--' p&$.

T'r' &% $o 5(&)# &%-or# o5 $'uro(u%u)r+&%or+'r%. T' p-&'$- r'por-% ' % $''r

+ $# o44&'% %u % /oo+9/or0&$* orr'6$&%&$* 5ur$&-ur' /&- po-'$-&) '3po%ur' -o-o3& *'$-%.


57/67

Nor() ('$-) %--u% $+ %p''u$+o%op& '3(&$-&o$ %o/% (&)+ A9

$&0&$* o5 -' '%%')%, 4u- -' r$&) $'r'%r' o-'r/&%' $or().

M&)+)# r'+u'+ (u%)' 4u)0 &% &$ -' %()) 5oo-(u%)'% $+ -'r' &% (&)+ )/&$* o5 -' -o'%.

To$' $+ oor+&$-&o$ -'%-&$* r' $or().

T' +''p -'$+o$ r''3'% r' $or() &$ -'

upp'r )&(4% $+ - -' 0$''%, 4u- 4%'$- --' $0)'%.

T' p)$-r r'%po$%'% r' '3or.


58/67

S'$%or# -'%-&$* %o/% %-o0&$* )o%% o5 )&*--ou, p&$pr&0, $+ -'(p'r-ur' %'$%-&o$%-o -' $0)'%, $+ )o%% o5 &4r-&o$ %'$%-&o$

- -' -o'%, 4u- propr&o'p-&o$ &% $or().T' po%-ur', *&-, -$+'( *&-, $+ Ro(4'r*

-'%-% r' $or(). T' p-&'$- &% 4)' -o /)0o$ '')% $+ -o'% /&-ou- +&u)-&'%.


59/67

,I;;E+ENTI-L

,I-GNO$I$D&4'-& N'urop-#Cu+ Eu&$ S#$+ro('

P'r$&&ou% $'(& $+ 12 D'6&'$#

7!1" >


60/67

D&4'-& N'urop-#,ecrease or loss o' !ibratoryLo%% o5 p&$pr&0 %'$%-&o$

Dr# %0&$

A4+o(&$) +&%-'$%&o$

Nausea an! vomiting

Constipation

Hig glucose

7!1" "B


61/67

Cauda Euina $yndrome

.ow bac) pain.ower limb motor wea)ness an! sensory

deficits

/rinary !ysfunction

Bowel disturbances- constipation

.oss of anal tone an! sensation

Sexual dysfunction


62/67

Pernicious -nemia and ")0,eciency

Peripheral loss of vibratory sense

.oss of posisition senseposition

0efle, loss an! mil!$to$mo!erate wea)ness

Babins)i1s responses an! ata,ia

2mpairment of pain te!perature and touch

sensations.

L-"O+-TO+%


63/67

L-"O+-TO+%

;IN,ING$G)#'-'+ H'(o*)o4&$ A1


64/67

L-"O+-TO+%

;IN,ING$N'r' o$+u-&o$ %-u+&'%u$-&--&' %'$%or# -r'%o)+% %o/%

')'-'+ &4r-&o$ p'r'p-&o$ -r'%o)+ - -'

-o'%,/&- $or() )'')% - -' 6$*'r%.T' oo)&$*9+'-'-&o$ $+ H'-9+'-'-&o$

-r'%o)+% r' ')'-'+ &$ -' 5''- $+ $or()&$ -' $+%.

7!1" ";


65/67

;inal ,iagnosis,iabetic Neuropaty

7!1"Hrr&%o$% Pr&$&p)'% o5 I$-'r$) M'+&&$',1- E+&-&o$ ">


66/67

E"#DE$%E BASED

&ED#%#$E

Evaluation of post-operative flow and dia!eter changes in brachial and ulnar


67/67

Evaluation of post-operative flow and dia!eter changes in brachial and ulnar

arteries in coronary artery bypass surgery patients in which the radial artery is

used as graft. O"?ECTI5E:

T' r+&) r-'r# &% /&+')# u%'+ &$ oro$r# 4#p%% %ur*'r#. I$ -'%' p-&'$-%, 5or'r(

$+ $+ &ru)-&o$ &% pro&+'+ 4# -' u)$r r-'r#. T&% %-u+# &('+ -o &$'%-&*-'po%-9op'r-&' $*'% &$ o/ $+ +&('-'r &$ 4r&) $+ u)$r r-'r&'% &$ p-&'$-%u$+'r*o&$* oro$r# 4#p%% %ur*'r# &$ /& -' r+&) r-'r# &% u%'+ % *r5-.

#ETHO,$:

'-/''$ S'p-'(4'r 2BB7 $+ S'p-'(4'r 2BB@, 2B p-&'$-%

Documents

Tingling and Numbness